Vivos Therapeutics (VVOS) Short Interest Ratio & Short Volume → He cracked the code to crypto… (From Weiss Ratings) (Ad) Free VVOS Stock Alerts $2.18 -0.31 (-12.45%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vivos Therapeutics Short Interest DataCurrent Short Volume62,800 sharesPrevious Short Volume191,100 sharesChange Vs. Previous Month-67.14%Dollar Volume Sold Short$158,884.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares2,980,000 sharesFloat Size2,760,000 sharesShort Percent of Float2.28%Today's Trading Volume103,217 sharesAverage Trading Volume171,905 sharesToday's Volume Vs. Average60% Short Selling Vivos Therapeutics ? Sign up to receive the latest short interest report for Vivos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVVOS Short Interest Over TimeVVOS Days to Cover Over TimeVVOS Percentage of Float Shorted Over Time Ad Manward PressThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company Vivos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202462,800 shares $158,884.00 -67.1%2.3%0.3 $2.53 4/15/2024191,100 shares $529,347.00 +921.9%7.6%0.9 $2.77 3/31/202418,700 shares $90,321.00 -28.6%0.8%0.1 $4.83 3/15/202426,200 shares $117,900.00 +11.0%2.3%0.2 $4.50 2/29/202423,600 shares $137,116.00 -19.2%2.1%0.1 $5.81 2/15/202429,200 shares $156,512.00 -38.1%2.6%0 $5.36 Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202447,200 shares $347,864.00 +237.1%4.2%0 $7.37 1/15/202414,000 shares $111,300.00 -84.0%1.2%0 $7.95 12/31/202387,300 shares $1.09 million -46.2%N/A0 $12.44 12/15/2023162,300 shares $1.49 million +512.5%14.6%0.1 $9.21 11/30/202326,500 shares $649,250.00 -31.2%2.4%0 $24.50 11/15/202338,500 shares $148,225.00 +13.2%3.9%0.2 $3.85 10/31/202334,000 shares $109,140.00 -98.5%3.4%0.2 $3.21 10/15/20232,270,000 shares $732,302.00 +297.1%N/A0.4 $0.32 9/30/2023571,600 shares $109,804.36 +8.3%N/A0.1 $0.19 9/15/2023527,700 shares $129,286.50 -18.9%N/A0.3 $0.25 8/31/2023650,300 shares $163,420.39 -43.0%N/A0.4 $0.25 8/15/20231,140,000 shares $372,096.00 +1,388.3%N/A0.7 $0.33 7/31/202376,600 shares $22,290.60 -33.6%N/A0.1 $0.29 7/15/2023115,300 shares $36,492.45 +63.3%N/A0.5 $0.32 6/30/202370,600 shares $36,006.00 -69.7%N/A0.5 $0.51 6/15/2023232,900 shares $128,421.06 -5.2%N/A1.4 $0.55 5/31/2023245,600 shares $93,720.96 +11.5%N/A1.3 $0.38 5/15/2023220,200 shares $72,666.00 +48.1%N/A0.3 $0.33 4/30/2023148,700 shares $51,152.80 -21.9%N/A0.2 $0.34 4/15/2023190,400 shares $63,574.56 +31.7%N/A0.3 $0.33 3/31/2023144,600 shares $49,323.06 -45.1%N/A0.2 $0.34 3/15/2023263,500 shares $96,599.10 +449.0%1.3%0.1 $0.37 2/28/202348,000 shares $29,280.00 -82.9%0.2%0 $0.61 2/15/2023281,000 shares $256,384.40 -5.9%1.4%0.1 $0.91 1/31/2023298,700 shares $325,583.00 -65.5%1.7%0.1 $1.09 1/15/2023865,100 shares $1.51 million +576.4%4.8%0.4 $1.75 12/30/2022127,900 shares $51,415.80 +10.6%0.7%0.1 $0.40 12/15/2022115,600 shares $40,286.60 -16.4%0.6%1.6 $0.35 11/30/2022138,200 shares $69,100.00 -17.8%0.8%3.5 $0.50 11/15/2022168,200 shares $115,368.38 -22.8%0.9%4.9 $0.69 10/31/2022217,900 shares $156,888.00 +29.0%1.2%5.2 $0.72 10/15/2022168,900 shares $116,000.52 -0.2%0.9%4 $0.69 9/30/2022169,300 shares $110,028.07 +19.1%0.9%4.2 $0.65 9/15/2022142,100 shares $161,994.00 -20.9%0.8%3.8 $1.14The most important AI company you've never heard of (Ad)Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth VVOS Short Interest - Frequently Asked Questions What is Vivos Therapeutics' current short interest? Short interest is the volume of Vivos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 62,800 shares of VVOS short. 2.28% of Vivos Therapeutics' shares are currently sold short. Learn More on Vivos Therapeutics' current short interest. What is a good short interest percentage for Vivos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.28% of Vivos Therapeutics' floating shares are currently sold short. Is Vivos Therapeutics' short interest increasing or decreasing? Vivos Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 62,800 shares, a drop of 67.1% from the previous total of 191,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vivos Therapeutics' float size? Vivos Therapeutics currently has issued a total of 2,980,000 shares. Some of Vivos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vivos Therapeutics currently has a public float of 2,760,000 shares. How does Vivos Therapeutics' short interest compare to its competitors? 2.28% of Vivos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Vivos Therapeutics: Vapotherm, Inc. (9.92%), Intelligent Bio Solutions Inc. (3.68%), ProSomnus, Inc. (1.18%), Avinger, Inc. (1.74%), NeuroMetrix, Inc. (1.04%), Plus Therapeutics, Inc. (1.10%), Venus Concept Inc. (0.56%), Sharps Technology, Inc. (1.27%), Acutus Medical, Inc. (1.44%), Aethlon Medical, Inc. (3.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Vivos Therapeutics stock? Short selling VVOS is an investing strategy that aims to generate trading profit from Vivos Therapeutics as its price is falling. VVOS shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vivos Therapeutics? A short squeeze for Vivos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VVOS, which in turn drives the price of the stock up even further. How often is Vivos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVOS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VAPO Short Interest INBS Short Interest OSA Short Interest AVGR Short Interest NURO Short Interest PSTV Short Interest VERO Short Interest STSS Short Interest AFIB Short Interest AEMD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VVOS) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders